QURE News

Pomerantz LLP Notifies Investors of Class Action Filing Against uniQure N.V. – QURE

QURE INVESTOR NOTICE: Hagens Berman Updates uniQure (QURE) Probe After FDA Criticism, Lawsuit Filed; April 13 Deadline Nears

Class Action Lawsuit Reminder from Pomerantz LLP for Investors of uniQure N.V. – QURE

QURE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Stockholders Have Opportunity to Lead Class Action Lawsuit!

Class Action Reminder from Pomerantz LLP for Shareholders of uniQure N.V. – QURE

QURE 9-DAY DEADLINE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data

Pomerantz LLP Updates Shareholders on Legal Action Brought Against uniQure N.V. – QURE

QURE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026

uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights

uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights